RAYONT INC.
Healthcare · Services-Misc Health & Allied Services, NEC · NV · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | |
|---|---|---|---|---|---|---|
| Revenue | $2.8M | $3.0M | $186,663 | — | $23,048 | $657,839 |
| Operating income | −$1.5M | −$661,502 | −$238,862 | −$2.3M | −$146,509 | −$383,991 |
| Net income | $244,858 | $383,884 | −$229,445 | −$2.3M | −$185,619 | −$385,097 |
| Total assets | $14.2M | $7.2M | $3.3M | $1.2M | $6,431 | $50,515 |
| Total liabilities | $9.1M | $3.4M | $2.3M | $203,797 | $227,693 | $86,158 |
| Equity | $5.1M | $3.7M | −$4,829 | $986,155 | −$221,262 | −$35,643 |
| EPS (diluted) | $0.01 | $0.01 | — | — | — | — |
| Shares out. | 50.2M | 46.8M | 46.6M | 12.9M | 1.9M | 37.7M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2022- Operating margin
- −52.3%
- Net margin
- 8.6%
- Return on equity
- 4.8%
- Return on assets
- 1.7%
- Return on capital (ROCE)
- −14.4%
- Liabilities / assets
- 64.1%
- Debt / equity
- 1.79×
- Book value / share
- $0.10
- Revenue growth (YoY)
- −4.4%
- Net income growth (YoY)
- −36.2%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2022- Altman Z″ (distress)
- -0.99distress
- Accruals / assets
- 0.5%clean
- Beneish M-Score
- -3.09normal
- Piotroski F-Score
- 3/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 2 warning● 2 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Revenue declined year-over-year
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Oct 3, 2022
- NT 10-Qmissed a reporting deadline ↗May 17, 2022
- NT 10-Qmissed a reporting deadline ↗Feb 15, 2022
- NT 10-Kmissed a reporting deadline ↗Sep 30, 2021
- NT 10-Qmissed a reporting deadline ↗Aug 14, 2020
- NT 10-Kmissed a reporting deadline ↗Jan 2, 2020
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Material events
SEC Form 8-K · most recent- Prior financials not reliable (restatement)Jun 23, 2023
- Entered a material agreementMay 5, 2023
- Director / officer changeMar 31, 2023
- Director / officer changeFeb 24, 2023
- Entered a material agreement · Regulation FD disclosureJul 7, 2022
- Regulation FD disclosureApr 25, 2022
- Director / officer changeApr 22, 2022
- Entered a material agreement · Regulation FD disclosureMar 23, 2022
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.